CLINICAL_TRIALS
trial_result
· 2019-02-06
Clinical Trial Update: Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes [Phase 3]
Summary
A Phase 3 trial comparing CinnaGen-liraglutide to Victoza (liraglutide) for type 2 diabetes, evaluating efficacy and safety; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cinnagen | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN